Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 24(2)2023 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-36675035

RESUMEN

The complexation of ß-cyclodextrin (ß-CD) with cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) was investigated using molecular docking and M062X/6-31G(d,p) calculations. The calculations suggested two possible complex formations of 1:1 and 2:1 host-guest molecular ratio of ß-CD with CBD and THC. The preferred orientation of all complexes in this study exhibited the hydrogen bonding between hydroxy-substituted benzene ring of CBD and THC with the ß-CD's secondary hydroxy groups at the wide rim. The calculated complexation energies indicate that formation of the 2:1 complexes (-83.53 to -135.36 kcal/mol) was more energetically favorable and chemically stable than the 1:1 complexes (-30.00 to -34.92 kcal/mol). However, the deformation energies of the host and the guest components in the 2:1 complexes (37.47-96.91 kcal/mol) are much higher than those in the 1:1 complexes (3.49-8.69 kcal/mol), which means the formation processes of the 2:1 complexes are more difficult due to the rigidity of the dimeric ß-CDs. Therefore, the inclusion complexes of ß-CD with CBD and THC are more likely to be in 1:1 host-guest ratio than in 2:1 molecular ratio. The results of this study supported the experimental results that the complexation constant of 1:1 ß-CD/CBD (Ks = 300 M-1) is greater than that of 2:1 ß-CDs/CBD (Kss = 0.833 M-1). Altogether, this study introduced the fitting parameters that could indicate the stability of the molecular fits in complex formation of each stoichiometry host-guest ratio, which are important for the assessment of the inclusion mechanisms as well as the relationships of reactants and products in chemical reactions.


Asunto(s)
Cannabidiol , beta-Ciclodextrinas , Simulación del Acoplamiento Molecular , Dronabinol , Teoría Funcional de la Densidad , beta-Ciclodextrinas/química
3.
Molecules ; 26(22)2021 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-34833875

RESUMEN

Stable encapsulation of medically active compounds can lead to longer storage life and facilitate the slow-release mechanism. In this work, the dynamic and molecular interactions between plumbagin molecule with ß-cyclodextrin (BCD) and its two derivatives, which are dimethyl-ß-cyclodextrin (MBCD), and 2-O-monohydroxypropyl-ß-cyclodextrin (HPBCD) were investigated. Molecular dynamics simulations (MD) with GLYCAM-06 and AMBER force fields were used to simulate the inclusion complex systems under storage temperature (4 °C) in an aqueous solution. The simulation results suggested that HPBCD is the best encapsulation agent to produce stable host-guest binding with plumbagin. Moreover, the observation of the plumbagin dynamic inside the binding cavity revealed that it tends to orient the methyl group toward the wider rim of HPBCD. Therefore, HPBCD is a decent candidate for the preservation of plumbagin with a promising longer storage life and presents the opportunity to facilitate the slow-release mechanism.


Asunto(s)
Naftoquinonas/química , beta-Ciclodextrinas/química , 2-Hidroxipropil-beta-Ciclodextrina/química , Biología Computacional/métodos , Ciclodextrinas/química , Composición de Medicamentos/métodos , Simulación de Dinámica Molecular , Solubilidad , Agua/química
4.
J Infect Public Health ; 14(9): 1206-1211, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34419704

RESUMEN

BACKGROUND: Coronavirus disease 2019 (COVID-19) has affected over 145 million infected people and 3 million deaths worldwide. There has been limited data to recommend either for or against use of antiviral regimens in mild COVID-19 patients. This study aimed to compare clinical outcomes between mild COVID-19 patients receiving antiviral drugs and those without. METHOD: Thai patients diagnosed with COVID-19 at field hospital affiliated to Thammasat University Hospital, Thailand were evaluated between January 1, 2020 and April 13, 2021. Patients' data, clinical presentation, past medical history, laboratory results, and treatment outcomes were extensively reviewed. RESULTS: Five hundred patients with positive tests were included in the study. The mean age was 35.9 years; 46% males. There were 225 (45%), 207 (41.4%), 44 (8.8%), 18 (3.6%), 6 (1.2%) patients with asymptomatic, mild, moderate, severe, and critical COVID-19, respectively. Of 207 mild COVID-19 patients, 9 (4.3%) received lopinavir/ritonavir or darunavir/ritonavir, 17 (8.2%) received favipiravir, while 175 (84.5%) had only supportive care. Mild COVID-19 patients receiving antiviral treatment had longer median length of hospital stay [13 days (IQR 11-14) vs. 10 days (IQR 8-12), p < 0.001] than patients having only supportive treatment. Antiviral drug use was significantly associated with longer hospital stay (>10 days) in mild COVID-19 patients (OR 5.52; 95%CI 2.12-14.40, p < 0.001). Adverse drug reactions such as diarrhea, abdominal pain, and hepatitis were also demonstrated in our COVID-19 patients with antiviral treatments. Majority of patients (97.6%) recovered without any complications and were discharged home. Two deaths were caused by acute respiratory distress syndrome from severe COVID-19 pneumonia. CONCLUSION: Antiviral treatment could not provide superior clinical outcomes to supportive care in mild COVID-19 patients. Mild COVID-19 patients receiving antiviral medication had longer length of hospital stay than those without. Standard supportive care and regular monitoring of disease progression might be keys for successful management of mild COVID-19.


Asunto(s)
Antivirales , COVID-19 , Adulto , Antivirales/uso terapéutico , Femenino , Humanos , Masculino , Unidades Móviles de Salud , Estudios Retrospectivos , SARS-CoV-2 , Resultado del Tratamiento
5.
Sci Pharm ; 86(2)2018 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-29762548

RESUMEN

Molecular interactions of plumbagin inclusion complexes with ß-cyclodextrin (BCD), dimethyl--cyclodextrin (MBCD), and hydroxypropyl-ß-cyclodextrin (HPBCD) were investigated by semi-empirical, Parameterization Method 6 and 7 (PM6, and PM7) in the aqueous phase using polarizable continuum calculations. The results revealed two different binding modes of the plumbagin molecule inside the BCD cavity with a negative value of the complexation energy. In conformation-I, the hydroxyl phenolic group of plumbagin was placed in the BCD cavity near the narrow-side of the host molecule. In the other model, conformation-II, the methyl quinone group of plumbagin was placed in the cavity of BCD near the narrow-side of the host molecule. The higher the negative value of the complexation energy, the more favorable is the pathway of inclusion-complex formation.

6.
Cell Mol Bioeng ; 11(1): 77-89, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31719880

RESUMEN

INTRODUCTION: Compound D and DMPBD are compounds extracted from Plai or Zingiber cassumunar Roxb., which have antiasthmatic properties. Thai herbal pharmacopoeia have indicated that approximate 50% of Thai prescriptions for asthma contain Plai. However, the inhibition mechanisms of these compounds are not clearly known. METHODS: In this study, molecular docking and molecular dynamics (MD) simulations have been used to simulate complex systems and analyze molecular interactions between these compounds and protein target, 5-lipoxygenase (5-LO) enzyme, which is an enzyme involved with asthma symptoms. RESULTS: From our MD simulations, Compound D and DMPBD molecules bind at the same binding site of its natural substrate (arachidonic acid) on 5-LO enzyme, which is similar to the binding of commercial asthma drug (Zileuton). Molecular mechanics generalized born surface area binding energy calculations of the 5-LO complex with Compound D and DMPBD are -26.83 and -29.15 kcal/mol, respectively. CONCLUSIONS: This work indicated that Compound D and DMPBD are competitive inhibitors, which are able to bind at the same 5-LO substrate binding site. This reveals opportunities for using Compound D and DMPBD as novel antiasthmatic drugs.

7.
Sci Pharm ; 85(4)2017 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-29160825

RESUMEN

Point mutations in Plasmodium falciparum dihydrofolate reductase (pfDHFR), especially the double mutant variant (A16V + S108T), led to ineffective inhibiting by cycloguanil (Cyc). Cycloguanil derivatives showed good inhibiting properties against wild-type and mutant pfDHFR with an inhibition constant as low as the nanomolar level. However, there have been no reports on the stereochemistry of the compounds, and this is important because the pure enantiomeric form of a chiral drug can exert desirable, as well as non-desirable responses on the body or both. In this work, three-dimensional structures of Cyc derivatives in R and S configuration were constructed and optimized using Hartree-Fock/6-31G (d,p). Their structures were docked into the binding pocket of wild-type and double mutant (A16V + S108T) pfDHFR, complexed with nicotinamide adenine dinucleotide phosphate (NADPH). Results indicate that both wild-type and mutant pfDHFR are enantioselective towards enantiomeric Cyc derivatives (R and S configuration).

8.
Sci Pharm ; 85(3)2017 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-28914808

RESUMEN

Dihydrofolate reductase (DHFR), an essential enzyme in the folate pathway, is a potential target for new anti-tuberculosis drugs. Fifteen crystal structures of Mycobacterium tuberculosis DHFR complexed with NADPH and various inhibitors are available in the RCSB Protein Data Bank, but none of them is a substrate binding structure. Therefore, we performed molecular dynamics simulations on ternary complexes of M. tuberculosis DHFR:NADPH with a substrate (dihydrofolate) and each of three competitive inhibitors the in 2,4-diaminopyrimidine series (P1, P157, and P169), in order to gain insight into the inhibition-mechanism of DHFR in the folate pathway. The binding energy and thermodynamics values of each system were calculated by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) method. The dynamics of the enzyme and the motion of each amino acid residue at the active site were examined. The key factors that promote the binding of P157 and P169 on M. tuberculosis DHFR (mtbDHFR) reveal opportunities for using these compounds as novel anti-tuberculosis drugs.

9.
Sensors (Basel) ; 17(9)2017 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-28895910

RESUMEN

Electronic noses (E-Noses) are becoming popular for food and fruit quality assessment due to their robustness and repeated usability without fatigue, unlike human experts. An E-Nose equipped with classification algorithms and having open ended classification boundaries such as the k-nearest neighbor (k-NN), support vector machine (SVM), and multilayer perceptron neural network (MLPNN), are found to suffer from false classification errors of irrelevant odor data. To reduce false classification and misclassification errors, and to improve correct rejection performance; algorithms with a hyperspheric boundary, such as a radial basis function neural network (RBFNN) and generalized regression neural network (GRNN) with a Gaussian activation function in the hidden layer should be used. The simulation results presented in this paper show that GRNN has more correct classification efficiency and false alarm reduction capability compared to RBFNN. As the design of a GRNN and RBFNN is complex and expensive due to large numbers of neuron requirements, a simple hyperspheric classification method based on minimum, maximum, and mean (MMM) values of each class of the training dataset was presented. The MMM algorithm was simple and found to be fast and efficient in correctly classifying data of training classes, and correctly rejecting data of extraneous odors, and thereby reduced false alarms.

10.
J Mol Graph Model ; 71: 13-27, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27835827

RESUMEN

Malaria is still one of the most serious diseases in tropical regions. This is due in part to the high resistance against available drugs for the inhibition of parasites, Plasmodium, the cause of the disease. New potent compounds with high clinical utility are urgently needed. In this work, we created a novel model using a regression tree to study structure-activity relationships and predict the inhibition constant, Ki of three different antimalarial analogues (Trimethoprim, Pyrimethamine, and Cycloguanil) based on their molecular descriptors. To the best of our knowledge, this work is the first attempt to study the structure-activity relationships of all three analogues combined. The most relevant descriptors and appropriate parameters of the regression tree are harvested using extremely randomized trees. These descriptors are water accessible surface area, Log of the aqueous solubility, total hydrophobic van der Waals surface area, and molecular refractivity. Out of all possible combinations of these selected parameters and descriptors, the tree with the strongest coefficient of determination is selected to be our prediction model. Predicted Ki values from the proposed model show a strong coefficient of determination, R2=0.996, to experimental Ki values. From the structure of the regression tree, compounds with high accessible surface area of all hydrophobic atoms (ASA_H) and low aqueous solubility of inhibitors (Log S) generally possess low Ki values. Our prediction model can also be utilized as a screening test for new antimalarial drug compounds which may reduce the time and expenses for new drug development. New compounds with high predicted Ki should be excluded from further drug development. It is also our inference that a threshold of ASA_H greater than 575.80 and Log S less than or equal to -4.36 is a sufficient condition for a new compound to possess a low Ki.


Asunto(s)
Antimaláricos/química , Malaria/tratamiento farmacológico , Pirimetamina/química , Trimetoprim/química , Antimaláricos/uso terapéutico , Humanos , Interacciones Hidrofóbicas e Hidrofílicas/efectos de los fármacos , Malaria/parasitología , Modelos Moleculares , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/patogenicidad , Pirimetamina/análogos & derivados , Pirimetamina/uso terapéutico , Relación Estructura-Actividad , Trimetoprim/análogos & derivados , Trimetoprim/uso terapéutico
11.
J Environ Manage ; 170: 70-8, 2016 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-26803257

RESUMEN

The utilization of fly ash as a solid sorbent material for CO2 capture via surface adsorption and carbonation reaction was evaluated as an economically feasible CO2 reduction technique. The results show that fly ash from a coal fired power plant can capture CO2 up to 304.7 µmol/g fly ash, consisting of 2.9 and 301.8 µmol/g fly ash via adsorption and carbonation, respectively. The CO2 adsorption conditions (temperature, pressure, and moisture) can affect CO2 capture performance of fly ash. The carbonation of CO2 with free CaO in fly ashes was evaluated and the results indicated that the reaction consumed most of free CaO in fly ash. The fly ashes after CO2 capture were further used for application as a mineral admixture for concrete. Properties such as water requirement, compressive strength, autoclave expansion, and carbonation depth of mortar and paste specimens using fly ash before and after CO2 capture were tested and compared with material standards. The results show that the expansion of mortar specimens using fly ash after CO2 capture was greatly reduced due to the reduction of free CaO content in the fly ash compared to the expansion of specimens using fresh fly ash. There were no significant differences in the water requirement and compressive strength of specimens using fly ash, before and after CO2 capture process. The results from this study can lead to an alternative CO2 capture technique with doubtless utilization of fly ash after CO2 capture as a mineral admixture for concrete.


Asunto(s)
Contaminantes Atmosféricos/química , Dióxido de Carbono/química , Ceniza del Carbón/química , Centrales Eléctricas , Contaminación del Aire/prevención & control , Contaminación Ambiental/prevención & control , Humanos
12.
Eur J Pharm Sci ; 47(4): 752-8, 2012 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-22922099

RESUMEN

The inclusion complexes of highly potent anti-HIV agent, UC781, with ß-cyclodextrin (ßCD), 2,6-dimethyl-ß-cyclodextrin (MßCD), and 2-hydroxypropyl-ß-cyclodextrin (HPßCD) in aqueous solution were investigated by molecular dynamics simulations. Simulations show that the phenyl ring of UC781 is trapped inside CD cavities, while the NH group of UC781 interacts with secondary hydroxyl groups at the wider rim of CDs. The different types of CDs directly affect the binding energy and the stability of the inclusion complexes. MßCD provides the most stable inclusion complex of UC781 among all CDs in this study due to the effect of methoxy groups (-OCH(3)) at C2 and C6 positions on the glucopyranose of CDs. Structure analysis of CDs and the orientation of UC781 inside CD cavities as well as the effects of aqueous solution to the inclusion complexes of UC781/CDs are discussed. Results of this study have provided an agreeable output; therefore, a reliable prediction method for other drug/CD inclusion complex formations is introduced.


Asunto(s)
Anilidas/química , Fármacos Anti-VIH/química , Ciclodextrinas/química , Furanos/química , Soluciones/química , 2-Hidroxipropil-beta-Ciclodextrina , Simulación de Dinámica Molecular , Tioamidas , beta-Ciclodextrinas/química
13.
Environ Technol ; 33(22-24): 2645-51, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23437665

RESUMEN

CO2 capture amine-enriched solid sorbent using agricultural wastes, such as bagasse, or industrial wastes, such as mullite, as support materials could provide efficient alternative CO2 reduction due to their low cost and ability to shape into many forms. These amine-enriched solid sorbents were prepared by treatment with monoethanolamine (MEA), diethanolamine, piperazine (PZ), 2-(2-aminoethyl-amino) ethanol (AEEA) and mixtures of these amines. The performance of amine-enriched solid sorbents with various amine compositions was studied in a tubular column at 1 atm and an adsorption temperature of 303 K. The CO2 capture capacities of the amine-enriched solid sorbents were determined by gas chromatography at a desorption temperature of 393 K. Amine-enriched solid sorbents in this study exhibited high performance CO2 capture. The MEA-PZ-enriched solid sorbent does have the highest CO2 capture performance of the amine-enriched bagasse support-based sorbents, and the results indicate that PZ is the most effective promoter in this study. The CO2 capture performances of solid sorbents in this study were compared with commercial solid sorbents. This study could lead to the development of low-cost solid sorbents for CO2 capture that can be used in many industrial applications.


Asunto(s)
Aminas/química , Dióxido de Carbono/química , Adsorción , Costos y Análisis de Costo , Piperazinas/química , Espectroscopía Infrarroja por Transformada de Fourier
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...